Shanghai Haixin Group Co., Ltd. (SHA:600851)

China flag China · Delayed Price · Currency is CNY
8.41
+0.13 (1.57%)
Apr 29, 2026, 2:25 PM CST
36.53%
Market Cap 6.96B
Revenue (ttm) 757.52M
Net Income (ttm) 176.00M
Shares Out 1.21B
EPS (ttm) 0.15
PE Ratio 56.79
Forward PE n/a
Dividend 0.05 (0.59%)
Ex-Dividend Date Jul 29, 2025
Volume 10,397,301
Average Volume 16,550,618
Open 8.13
Previous Close 8.28
Day's Range 7.93 - 8.41
52-Week Range 6.05 - 9.18
Beta 0.67
RSI 48.81
Earnings Date Apr 22, 2026

About Shanghai Haixin Group

Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics and clothing. The company was founded in 1986 and is headquartered in Shanghai, China. [Read more]

Industry Conglomerates
Sector Industrials
Founded 1986
Employees 715
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600851
Full Company Profile

Financial Performance

In 2025, Shanghai Haixin Group's revenue was 757.52 million, a decrease of -4.82% compared to the previous year's 795.88 million. Earnings were 176.00 million, an increase of 16.60%.

Financial Statements

News

There is no news available yet.